Ultrastructural Immunostaining of Infiltrating Ductal Breast Carcinomas with the Monoclonal Antibody H: A Comparative Study with Cytokeratin 8

References

• Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention, ed 2. Oxford, UK: Oxford University Press; 1996; 1022–1039.
   Google Scholar
• Rosen PP. The pathological classification of human mammary carcinoma: past, present and future. Ann Clin Lab Sci. 1979;9:144–156.
   PubMed Web of Science ®Google Scholar
• Tulinius H, Bjarnason O, Sigvaldason H, Bjarnadottir G, Olafsdottir G. Tumours in Iceland, 10; malignant tumours of the female breast - a histological classification, laterality, survival and epidemiological considerations. APMIS. 1988;96:229–238.
   PubMed Web of Science ®Google Scholar
• Rosen PP. Invasive duct carcinoma and morphological prognostic markers. In: Rosen PP, ed. Breast Pathology. Philadelphia: Lippincott-Raven; 1997;275-293.
   Google Scholar
• Ahmed A. Atlas of the Ultrastructure of Human Breast Diseases. London: Churchill-Livingstone; 1978.
   Google Scholar
• Gallager SH. Pathologic types of breast cancer: their prognoses. Cancer. 1984;53:623–629.
   PubMed Web of Science ®Google Scholar
• Goldenberg VE, Goldenberg NS, Sommers SC. Comparative ultrastructure of atypical ductal hyperplasia, intraductal carcinoma and infiltrating ductal carcinoma of the breast. Cancer. 1969;24:1152–1169.
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I, Minafra S, Faccini AM, Alessandro R. An ultrastructural evaluation of cell heterogeneity in invasive ductal carcinomas of the human breast, I: an in vivo study. J Submicrosc Cytol Pathol. 1989;21:475–488.
   PubMedGoogle Scholar
• Querzoli P, Albonico G, Ferretti S, Rinaldi R, Magri E, Nenci I. Quantitative immunoprofiles of breast cancer performed by image analysis. Anal Quant Cytol Histol. 1999;21:151–160.
   PubMed Web of Science ®Google Scholar
• Altenstrasser F, Weger AR, Lindholm J, Gschwendter A, Mairinger T. Reproducibility and efficiency testing of two sampling methods for image analysis in cytology. Anal Quant Cytol Histol. 1998;20:92–96.
   PubMed Web of Science ®Google Scholar
• Ghadially FN. Diagnostic Electron Microscopy of Tumors, ed 2. London: Butterworths; 1985.
   Google Scholar
• Djabali K. Cytoskeletal proteins connecting intermediate filaments to cytoplasmic and nuclear periphery. Histol Histopathol. 1999;14:501–509.
   PubMed Web of Science ®Google Scholar
• Dickersin GR. Diagnostic Electron Microscopy: A Text=Atlas, ed 2. New York: Springer; 2000.
   Google Scholar
• Franke WW, Schiller DL, Moll R, et al. Diversity of cytokeratins: differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol. 1981;153:933–959.
   PubMed Web of Science ®Google Scholar
• Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratin polypeptides: patterns of expression of specific cytokeratins in normal epithelia, tumors and cultured cells. Cell. 1982;31:11–24.
   PubMed Web of Science ®Google Scholar
• Franke WW, Schiller DL, Hatzfeld M, Winter S. Protein complexes of intermediated-sized filaments: melting of cytokeratin complexes in urea reveals different polypeptide separation characteristics. Proc Natl Acad Sci USA. 1983;80:7113–7117.
   PubMed Web of Science ®Google Scholar
• Moll R, Schiller DL, Franke WW. Identification of protein IT of intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol. 1990;111:567–580.
   PubMed Web of Science ®Google Scholar
• Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–439.
   PubMed Web of Science ®Google Scholar
• Fuchs E, Coppock SM, Green H, Cleveland DW. Two distinct classes of keratin genes and their evolutionary significance. Cell. 1981;27:75–84.
   PubMed Web of Science ®Google Scholar
• Kim KH, Rheinwald JG, Fuchs E. Tissue specificity of epithelial keratins: differential expressions of mRNAs from two multigene families. Mol Cell Biol. 1983;3:495–502.
   PubMed Web of Science ®Google Scholar
• Kim KH, Marchuk D, Fuchs E. Expression of unusually large keratins during terminal differentiation: balance of type II keratins is not disrupted. J Cell Biol. 1984;99:1872–1877.
   PubMed Web of Science ®Google Scholar
• Fuchs E. Keratins as biochemical markers of epithelial differentiation. Trends Genet. 1988;4:277–281.
   PubMed Web of Science ®Google Scholar
• Franke WW, Schmid E, Weber K, Osborn M. HeLa cells contain intermediate-sized filaments of the prekeratin type. Exp Cell Res. 1979;118:95–109.
   PubMed Web of Science ®Google Scholar
• Van Muijen GNP, Ruiter DJ, Franke WW, et al. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins 4 and 13. Exp Cell Res. 1986;162:97–113.
   PubMed Web of Science ®Google Scholar
• Osborn M, Weber K. Tumour diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest. 1983;48:372–394.
   PubMed Web of Science ®Google Scholar
• Cooper DS, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest. 1985;52:243–256.
   PubMed Web of Science ®Google Scholar
• Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. Am J Clin Pathol. 1985;84:413–424.
   PubMed Web of Science ®Google Scholar
• Bartek J, Vojtesek B, Staskova Z, Bartkova J, Kerekes Z, Rejthar A series if 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology. J Pathol. 1991;164:215–224.
   PubMed Web of Science ®Google Scholar
• Miettinen M. Keratin immunohistochemistry: update on applications and pitfalls. Pathol Annu. 1993;8:113–143.
   Google Scholar
• Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Bocker WJ. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol. 1988;19:276–289.
   PubMed Web of Science ®Google Scholar
• Trask DK, Band V, Zajchowski DA, Yaswen P, Suh T, Sager R. Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci USA. 1990;87:2319–2323.
   PubMed Web of Science ®Google Scholar
• Heatley M, Maxwell P, Whiteside C, Toner P. Cytokeratin intermediate filament expression in benign and malignant breast disease. J Clin Pathol. 1995;48:26–32.
   PubMed Web of Science ®Google Scholar
• Moll R, Krepler R, Franke WW. Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation. 1983;23:256–269.
   PubMed Web of Science ®Google Scholar
• Quinlan RA, Schiller DL, Hatzfeld M, et al. Patterns of expression and organization of cytokeratin intermediate filaments. In: Wang E, Fishman D, Liem RRH, Sun T-T, eds. Intermediate Filaments. Ann NY Acad Sci. New York: NYAS 1985;455:282–306.
   Google Scholar
• Takei H, Lino Y, Horiguchi J, et al. Immunohistochemical analysis of cytokeratin 8 as a prognostic factor in invasive breast carcinoma. Anticancer Res. 1995;15:1101–1106.
   PubMed Web of Science ®Google Scholar
• Godfroid E, Geuskens M, Dupressoir T, Parent I, Szpirer C. Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells. J Cell Sci. 1991;99:595–607.
   PubMed Web of Science ®Google Scholar
• Hembrough TA, Vasudevan J, Allietta MM, Glass II WF, Gonias SL. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci. 1995;108:1071–1082.
   PubMed Web of Science ®Google Scholar
• Chan R, Rossitto PV, Edwards BF, Cardiff RD. Presence of proteolytically processed keratins in the culture medium of MCF-7 cells. Cancer Res. 1986;46:6353–6359.
   PubMed Web of Science ®Google Scholar
• Hembrough TA, Gonias SL. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J Biol Chem. 1996;271:25684–25691.
   PubMed Web of Science ®Google Scholar
• Weber K, Osborn M, Moll R, Wiklund B, Luning B. Tissue polypeptide antigen (TPA) is related to the nonepidermal keratins 8, 18 and 19 typical of simple and nonsquamous epithelia: re-evaluation of a human tumor marker. EMBO J. 1984;3:2707–2714.
   PubMed Web of Science ®Google Scholar
• Arvanitis DL, Kouklis P, Mori de Moro G, Goutas N, Kittas C, Szuchet S. Immunostaining of ductal breast carcinoma with the monoclonal antibody H. Oncol Rep. 1995;2:991–995.
   PubMed Web of Science ®Google Scholar
• Arvanitis DL, Stavridou AI, Mori de Moro G, Szuchet S. Reactive astrocytes upregulate one or more gene products that are recognized by monoclonal antibody H. Cell Tissue Res. 2001;304:11–19.
   PubMed Web of Science ®Google Scholar
• Chou C-F, Smith AJ, Omary MB. Characterization and dynamics of O-linked glycosylation of human cytokeratins 8 and 18. J Biol Chem. 1992;267:3901–3906.
   PubMed Web of Science ®Google Scholar
• Haltiwanger RS, Kelly WG, Roquemore EP, et al. Glycosylation of nuclear and cytoplasmic proteins is ubiquitous and dynamic. Biochem Soc Trans. 1992;20:264–269.
   PubMed Web of Science ®Google Scholar
• Haltiwanger RS, Busby S, Grove K, et al. O-glycosylation of nuclear and cytoplasmic proteins: analogous to phosphorylation? Biochem Biophys Res Commun. 1997;231:237–242.
   Google Scholar
• Hart GW. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem. 1997;66:315–335.
   PubMed Web of Science ®Google Scholar
• Kreppel LK, Blomberg MA, Hart GW. Dynamic glycosylation of nuclear and cytosolic proteins. J Biol Chem. 1997;272:9308–9315.
   PubMed Web of Science ®Google Scholar
• Erlandson RA. Diagnostic Transmission Electron Microscopy of Tumors. New York: Raven Press, 1994.
   Google Scholar
• Dvorak AM, Monahan-Earley RA. Diagnostic Ultrastructural Pathology, I. Boca Raton, CRC Press; 2000.
   Google Scholar
• Tucker JA. The continuing value of electron microscopy in surgical pathology. Ultrastruct Pathol. 2000;24:383–389.
   PubMed Web of Science ®Google Scholar
• Ordó ñ ez NG, Mackay B Electron microscopy in tumor diagnosis: indications for its use in the immunohistochemical era. Hum Pathol. 1998;29:1403–1411
   PubMed Web of Science ®Google Scholar
• Verkleij AJ, Koster AJ, Mu« ller WH, Humberl BM. Immunogold labeling in transmission electron microscopy. In: Thiery JP, ed. Molecular Mechanisms of Transcellular Signaling. Amsterdam: IOS Press; 1999:339–355.
   Google Scholar
• Faulk WP, Taylor GM. An immunocolloid method for the electron microscope. Immunocytochemistry. 1971;8:1081–1083.
   PubMedGoogle Scholar
• Beier K, Fahimi HD. Automatic determination of labeling density in protein A-gold immunocytochemical preparations using an image analyzer: application to peroxisomal enzymes. Histochemistry. 1985;82:99–100.
   PubMedGoogle Scholar
• Pulczynski S, Jensen OM. Quantitation of immunogold with an interactive image analysis system: a new, practical approach to antibody-induced modulation, internalization and intracellular transport of surface antigens in viable hematopoietic cells. Anal Quant Cytol Histol. 1994;16:393–399.
   PubMed Web of Science ®Google Scholar
• Gracia-Navarro F, Ruiz-Navarro A, Garc S, J. Transmission electron microscopy. Wootton R, Springall DR, Polak JM, eds. Image Analysis in Histology: Conventional and Confocal Microscopy. Cambridge, UK: Cambridge University Press; 1995:197–210.
   Google Scholar
• Hisano S, Adachi T, Maegawa M, Daikoku S. Some improvement in tissue preparation and colloidal-gold immunolabeling for electron microscopy. Am J Anat. 1986;175:245–266.
   PubMedGoogle Scholar
• Slot JW, Posthuma G, Ghang LY, Crapo JD, Geuze HJ. Quantitative aspects of immunogold labeling in embedded and in nonembedded sections. Am J Anat. 1989;185:271–281.
   PubMedGoogle Scholar
• Fahimi HD, Reich D, Volkl A, Baumgart E. Contributions of the immunogold technique to investigation of the biology of peroxisomes. Histochem Cell Biol. 1996;106:105–114.
   PubMed Web of Science ®Google Scholar
• Bloom HJG, Richardson HH. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for fifteen years. Br J Cancer. 1957;11:359–377.
   PubMed Web of Science ®Google Scholar
• Causton B. The choice of resins for electron immunocytochemistry. In: Polak JM, Varndell IM, eds. Immunolabelling for Electron Microscopy. Amsterdam: Elsevier; 1984:29–36.
   Google Scholar
• Bendayan M, Zollinger M. Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique. J Histochem Cytochem. 1983;31:101–109.
   PubMed Web of Science ®Google Scholar
• Polak JM, Van Noorden S. Post-embedding immunocytochemistry for the transmission electron In: Polak JM, Van Noorden S, eds. Introduction to Immunocytochemistry. Oxford, UK: Bios Scientific; 1997:81–89.
   Google Scholar
• Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963–974.
   PubMed Web of Science ®Google Scholar
• Holt GD, Hart GW. The subcellular distribution of terminal N-acetylglucosamine moieties: localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem. 1986;261:8049–8057.
   PubMed Web of Science ®Google Scholar
• Chandra NC, Spiro MJ, Spiro RG. Identification of a glycoprotein from rat liver mitochondrial inner membrane and demonstration of its origin in the endoplasmic reticulum. J Biol Chem. 1998;273:19715–19721.
   PubMed Web of Science ®Google Scholar
• Go« rlach M, Meyer HE, Elsermann B, Soboll S. cAMP-dependent phosphorylation of cytokeratin in hepatic inner mitochondrial membrane. Biol Chem Hoppe-Seyler. 1995;376:51–55.
   Google Scholar
• Abeijon C, Hirschberg CB. Intrinsic membrane glycoproteins with cytosol-oriented sugars in the endoplasmic reticulum. Proc Natl Acad Sci USA. 1988;85:1010–1014.
   PubMed Web of Science ®Google Scholar
• Kelly WG, Hart GW. Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell. 1989;57:243–251.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Tjian R. Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc Natl Acad Sci USA. 1989;86:1781–1785.
   PubMed Web of Science ®Google Scholar
• Reason AJ, Morris HR, Panico M, et al. Localization of O-GlcNAc modification on the serum response transcription factor. J Biol Chem. 1992;267:16911–16921.
   PubMed Web of Science ®Google Scholar
• Privalsky ML. A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated. J Virol. 1990;64:463–466.
   PubMed Web of Science ®Google Scholar
• Chou T-Y, Hart GW, Dang CV. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem. 1995;270:18961–18965.
   PubMed Web of Science ®Google Scholar
• Shaw P, Freeman J, Bovey R, Iggo R. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene. 1996;12:921–930.
   PubMed Web of Science ®Google Scholar
• Jiang MS, Hart GW. A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine. J Biol Chem. 1997;272:2421–2428.
   PubMed Web of Science ®Google Scholar
• Cheng X, Hart GW. Glycosylation of the murine estrogen receptor-alpha. J Steroid Biochem Mol Biol. 2000;75:147–158.
   PubMed Web of Science ®Google Scholar
• Ward WS, Schmidt WN, Schmidt CA, Hnilica LS. Association of cytokeratin p39 with DNA in intact Novikoff hepatoma cells. Proc Natl Acad Sci USA. 1984;81:419–423.
   PubMed Web of Science ®Google Scholar
• Tolstonog GV, Sabasch M, Traub P. Cytoplasmic intermediate filaments are stably associated with nuclear matrices and potentially modulate their DNA-binding function. DNA Cell Biol. 2002;21:213–239.
   PubMed Web of Science ®Google Scholar
• Spencer VA, Coutts AS, Samuel SK, Murphy LC, Davie JR. Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J Biol Chem. 1998;273:29093–29097.
   PubMed Web of Science ®Google Scholar
• Dolo V, Adobati E, Canevari S, Picone MA, Vittorelli ML. Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis. 1995;13:277–286.
   PubMed Web of Science ®Google Scholar
• Leube RE, Bosch FX, Romano V, Zimbelmann R, Hofler H, Franke WW. Cytokeratin expression in simple epithelia, III: detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ. Differentiation. 1986;33:69–85.
   PubMed Web of Science ®Google Scholar
• Sundstrom BE, Stigbrand TI. Cytokeratins and tissue polypeptide antigen. Int J Biol Markers. 1994;9:102–108.
   PubMedGoogle Scholar
• Gonias SL, Hembrough TA, Sankovic M. Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells. Front Biosci. 2001;6:1403–1411.
   Google Scholar
• Riopel CL, Butt I, Omary MB. Method of cell handling affects leakiness of cell surface labeling and detection of intracellular keratins. Cell Motil Cytoskel. 1993;26:77–87.
   PubMed Web of Science ®Google Scholar
• Asch HL, Mayhew E, Lazo RO, Asch BB. Lipids covalently bound to keratins of mouse mammary epithelial cells. Biochem Mol Biol Int. 1993;29:1161–1169.
   PubMedGoogle Scholar
• Slawson C, Pidala J, Potter R. Increased N-acetyl-b-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta. 2001;1537:147–157.
   PubMed Web of Science ®Google Scholar
• Zachara NE, Hart GW. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev. 2002;102:431–438.
   PubMed Web of Science ®Google Scholar